Clinical Trial Update: Study of Trastuzumab-emtansine in Patients With HER2-positive Metastatic Colorectal Cancer Progressing After Trastuzumab and Lapatinib. [Phase 2]

View source ↗

Summary

Phase 2 trial of trastuzumab-emtansine in HER2-positive metastatic colorectal cancer after prior trastuzumab and lapatinib.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Trastuzumab emtansine (ado-trastuzumab emtansine)

Snippet

Sponsor: Fondazione del Piemonte per l'Oncologia | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: UNKNOWN